DRUG · Mapped RxNorm record
Etanercept
Normalized identity: etanerceptView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
NCT00837434
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Adalimumab
Normalized identity: adalimumabView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedAnti-TNF Agents for the Treatment of Rheumatoid Arthritis
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Interventions
EtanerceptDRUG · verified · RxNorm: etanercept
AdalimumabDRUG · verified · RxNorm: adalimumab
Sponsors & collaborators
Autoimmunity Centers of Excellencecollaborator
Rho Federal Systems Division, Inc.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00837434 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.